Table 3.
Univariate analysis of overall and relapse free survival in patients with lung cancer.
| Overall survival | Relapse free survival | |||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
| Age | 1.03 | 0.74–1.43 | 0.867 | 0.95 | 0.63–1.43 | 0.819 |
| Gender | 1.14 | 0.93–1.40 | 0.201 | 0.94 | 0.73–1.20 | 0.613 |
| Histological type | 1.12 | 0.91–1.36 | 0.282 | 0.63 | 0.49–0.82 | < 0.001 |
| T classification | 1.42 | 1.25–1.61 | < 0.001 | 1.35 | 1.14–1.59 | < 0.001 |
| N classification | 1.39 | 1.22–1.57 | < 0.001 | 1.41 | 1.20–1.65 | < 0.001 |
| M classification | 1.16 | 0.91–1.49 | 0.220 | 0.83 | 0.62–1.11 | 0.210 |
| Radiation therapy | 1.00 | 0.79–1.27 | 0.983 | 1.76 | 1.32–2.35 | < 0.001 |
| Residual tumor | 1.17 | 1.03–1.33 | 0.016 | 1.29 | 1.11–1.49 | 0.001 |
| Stage | 1.48 | 1.33–1.64 | < 0.001 | 1.41 | 1.23–1.62 | < 0.001 |
| KLRK1 expression | 0.74 | 0.60–0.91 | 0.004 | 0.68 | 0.52–0.88 | 0.003 |